Form 4: American Battery Materials Director Adam Lipson Reports Beneficial Ownership Changes

Sentiment:

SEC Form 4


Director Adam Lipson reports changes in beneficial ownership of American Battery Materials, Inc. stock, including acquisitions through warrant exercises and conversions of preferred stock and convertible notes.

Capital raiseA $10,000 convertible note was issued on 2/27/2025.The convertible note is convertible at a 25% discount to the company's proposed uplist price, tentatively $4.00.

Summary

  • Adam Lipson, a director of American Battery Materials, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
  • The reported transactions include the acquisition of common stock through the exercise of warrants on multiple dates in 2023 at prices ranging from $1.50 to $4.80, resulting in the acquisition of 19,231 shares.
  • Lipson also acquired 6,667 shares of common stock through the conversion of Series A Preferred Stock on August 23, 2023.
  • Additionally, Lipson acquired 1,112 shares of common stock on May 22, 2024, at a price of $0.30.
  • Lipson also acquired 2,500 shares of common stock through the conversion of a convertible note on February 27, 2025.
  • Lipson's total direct ownership of common stock following these transactions is 314,971 shares.
  • Lipson also acquired 16,000 common stock options with an exercise price of $1.55, exercisable from December 8, 2024, to December 8, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While a director increasing their stake is generally positive, the document primarily reflects routine transactions. The convertible note indicates a potential future capital raise.

Positives

  • The director's increased stake in the company could be interpreted as a sign of confidence in its future prospects.
  • The exercise of warrants provides the company with additional capital.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder confidence due to the director's increased investment.

Key Dates

DateDescription
02/28/2023Warrant exercise resulting in acquisition of 1,798 shares of common stock at $2.40.
03/27/2023Warrant exercise resulting in acquisition of 6,141 shares of common stock at $1.80.
04/08/2023Warrant exercise resulting in acquisition of 2,136 shares of common stock at $1.50.
05/22/2023Purchase of 1,112 shares of common stock at $2.40.
08/07/2023Warrant exercise resulting in acquisition of 4,589 shares of common stock at $4.80.
08/23/2023Conversion of Series A Preferred Stock resulting in acquisition of 6,667 shares of common stock at $3.60 and 34 shares of Series A Preferred Stock at $1.
12/08/2024Date from which 16,000 common stock options become exercisable.
05/22/2024Purchase of 1,112 shares of common stock at $0.30.
02/27/2025Convertible note issued on 2/27/2025 convertible at a 25% discount to the company's proposed uplist pricetentatively, $4.00.
03/03/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.